Literature DB >> 19447852

PET/MRI: the blended-modality choice of the future?

Norman E Bolus1, Remo George, Johrnee' Washington, Bradley R Newcomer.   

Abstract

This article addresses the emerging technology of PET coupled with MRI, or PET/MRI, which could become the technology of choice in the future for many reasons. Some of these reasons will be discussed, along with a historical account of the field of MRI and how this modality has evolved to include many aspects of molecular and functional imaging. After reading this article, nuclear medicine technologists should be able to provide an overview of the history of MRI, discuss PET and how it is mainly used today melded to CT as PET/CT, discuss how MRI is used diagnostically, explain how PET technology and MRI technology are able to function simultaneously together as PET/MRI, discuss some issues concerning who will operate these new units, and discuss the possibility that PET/MRI could be the blended technology of choice in the future.

Mesh：

Year:  2009        PMID： 19447852     DOI： 10.2967/jnmt.108.060848

Source DB:  PubMed          Journal:  J Nucl Med Technol        ISSN： 0091-4916


  6 in total

Review 1.  Current status and future role of brain PET/MRI in clinical and research settings.

Authors:  P Werner; H Barthel; A Drzezga; O Sabri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-09       Impact factor: 9.236

2.  Differentiation of glioma and radiation injury in rats using in vitro produce magnetically labeled cytotoxic T-cells and MRI.

Authors:  Ali S Arbab; Branislava Janic; Kourosh Jafari-Khouzani; A S M Iskander; Sanath Kumar; Nadimpalli R S Varma; Robert A Knight; Hamid Soltanian-Zadeh; Stephen L Brown; Joseph A Frank
Journal:  PLoS One       Date:  2010-02-26       Impact factor: 3.240

3.  Al(OH)3 facilitated synthesis of water-soluble, magnetic, radiolabelled and fluorescent hydroxyapatite nanoparticles.

Authors:  X Cui; M A Green; P J Blower; D Zhou; Y Yan; W Zhang; K Djanashvili; D Mathe; D S Veres; K Szigeti
Journal:  Chem Commun (Camb)       Date:  2015-06-07       Impact factor: 6.222

Review 4.  Cerebral metabolism in major depressive disorder: a voxel-based meta-analysis of positron emission tomography studies.

Authors:  Liang Su; Yiyun Cai; Yifeng Xu; Anirban Dutt; Shenxun Shi; Elvira Bramon
Journal:  BMC Psychiatry       Date:  2014-11-19       Impact factor: 3.630

5.  Synthesis, Characterization, and Application of Core-Shell Co0.16Fe2.84O4@NaYF4(Yb, Er) and Fe3O4@NaYF4(Yb, Tm) Nanoparticle as Trimodal (MRI, PET/SPECT, and Optical) Imaging Agents.

Authors:  Xianjin Cui; Domokos Mathe; Noémi Kovács; Ildikó Horváth; Maite Jauregui-Osoro; Rafael Torres Martin de Rosales; Gregory E D Mullen; Wilson Wong; Yong Yan; Dirk Krüger; Andrei N Khlobystov; Maria Gimenez-Lopez; Mariann Semjeni; Krisztián Szigeti; Dániel S Veres; Haizhou Lu; Ignacio Hernández; William P Gillin; Andrea Protti; Katalin Kis Petik; Mark A Green; Philip J Blower
Journal:  Bioconjug Chem       Date:  2015-08-14       Impact factor: 4.774

Review 6.  Morphological and functional MDCT: problem-solving tool and surrogate biomarker for hepatic disease clinical care and drug discovery in the era of personalized medicine.

Authors:  Liang Wang
Journal:  Hepat Med       Date:  2010-08-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.